安徽医学
安徽醫學
안휘의학
Anhui Medical Journal
2015年
9期
1058-1060
,共3页
程晓光%张振华%王长泰%俞舒%李旭
程曉光%張振華%王長泰%俞舒%李旭
정효광%장진화%왕장태%유서%리욱
乙型肝炎表面抗原%慢性乙型肝炎%原发性肝癌%HBV-DNA载量
乙型肝炎錶麵抗原%慢性乙型肝炎%原髮性肝癌%HBV-DNA載量
을형간염표면항원%만성을형간염%원발성간암%HBV-DNA재량
Hepatitis B surface antigen%Chronic Hepatitis B%Hepatocelluar carcinoma%Hepatitis B viral load
目的:比较慢性乙型肝炎( CHB)与HBV相关性原发性肝癌患者中乙肝表面抗原( HBsAg)和HBV DNA载量情况。方法采用化学发光法检测403例CHB及肝细胞肝癌( HCC)患者血清乙型肝炎病毒标志物滴度,采用荧光定量PCR技术检测患者血清HBV DNA载量。403例患者按照临床诊断分为CHB组(209例)和HCC组(194例)。结果 CHB组:血清HBsAg 滴度≥250 IU/mL者占89.00%;HBV DNA≥1000 copies /mL者占88.40%。 HCC组:血清HBsAg滴度≥250 IU/mL者占79.90%;HBV DNA≥1000 copies /mL 者占67.70%。两组HBsAg≥250 IU/mL患者的比例差异、HBV DNA≥1000 copies/mL 患者的比例差异均有统计学意义(P<0.05)。结论与CHB相比,HBV相关性原发性肝癌患者HBsAg、HBV DNA载量较低。
目的:比較慢性乙型肝炎( CHB)與HBV相關性原髮性肝癌患者中乙肝錶麵抗原( HBsAg)和HBV DNA載量情況。方法採用化學髮光法檢測403例CHB及肝細胞肝癌( HCC)患者血清乙型肝炎病毒標誌物滴度,採用熒光定量PCR技術檢測患者血清HBV DNA載量。403例患者按照臨床診斷分為CHB組(209例)和HCC組(194例)。結果 CHB組:血清HBsAg 滴度≥250 IU/mL者佔89.00%;HBV DNA≥1000 copies /mL者佔88.40%。 HCC組:血清HBsAg滴度≥250 IU/mL者佔79.90%;HBV DNA≥1000 copies /mL 者佔67.70%。兩組HBsAg≥250 IU/mL患者的比例差異、HBV DNA≥1000 copies/mL 患者的比例差異均有統計學意義(P<0.05)。結論與CHB相比,HBV相關性原髮性肝癌患者HBsAg、HBV DNA載量較低。
목적:비교만성을형간염( CHB)여HBV상관성원발성간암환자중을간표면항원( HBsAg)화HBV DNA재량정황。방법채용화학발광법검측403례CHB급간세포간암( HCC)환자혈청을형간염병독표지물적도,채용형광정량PCR기술검측환자혈청HBV DNA재량。403례환자안조림상진단분위CHB조(209례)화HCC조(194례)。결과 CHB조:혈청HBsAg 적도≥250 IU/mL자점89.00%;HBV DNA≥1000 copies /mL자점88.40%。 HCC조:혈청HBsAg적도≥250 IU/mL자점79.90%;HBV DNA≥1000 copies /mL 자점67.70%。량조HBsAg≥250 IU/mL환자적비례차이、HBV DNA≥1000 copies/mL 환자적비례차이균유통계학의의(P<0.05)。결론여CHB상비,HBV상관성원발성간암환자HBsAg、HBV DNA재량교저。
Objective To compare the HBsAg and HBV DNA load between chronic Hepatitis B ( CHB) and HBV-related hepatocel-lular carcinoma ( HCC) patients. Methods A total of 403 patients with chronic Hepatitis B ( CHB) and HCC were enrolled. HBV serologi-cal markers were tested by chemoluminescence method, and serum HBV-DNA level was detected by fluorescent quantitation PCR technology. All patients were divided into CHB group(209 patients) and HCC group(194 patients) according to clinical diagnosis. Results In CHB group, 89. 00% patients had serum HBsAg titers≥250 IU/mL and 88. 40% patients had HBV DNA≥1 000 copies/mL. In the meantime, 79. 90% and 67. 70% patients with HCC had serum HBsAg titers≥250 IU/mL and HBV DNA≥1 000 copies/mL, respectively. The differ-ences in HBsAg≥250 IU/mL, HBV DNA≥1 000 copies/mL between the two groups was significant (P<0. 05). Conclusion Compared with chronic hepatitis B, the patients of HBV-related hepatocellular carcinoma has lower HBsAg and HBV DNA load.